临床试验缺乏数据收集阻碍评估残疾人纳入情况
该研究审查了2016至2021年英国国家健康研究所图书馆发表的随机对照试验报告,评估试验团队是否收集残疾人数据。结果显示,407份报告中无一项将残疾作为人口学特征收集,仅27%因其他目的收集部分残疾数据,作者认为残疾在试验中被忽视,威胁试验的普遍性并可能加剧健康不平等。
要点
- 407份随机对照试验报告中,无一项将残疾作为人口学特征收集。
- 27%(109/407)因其他目的收集部分残疾数据,最常用问卷(65%;71/109)。
- 作者认为残疾在试验中被忽视,残疾人需求在试验中未得到充分服务。
核心结论
- 残疾在试验中不仅被记录不足或报告不足,而且被忽视;由于未将残疾作为人口学特征收集,残疾人在试验中仍未得到充分服务;全球16%人口患有残疾,这威胁所有试验的普遍性并可能加剧残疾人的健康不平等。
研究设计与样本
- 审查2016至2021年英国国家健康研究所图书馆发表的随机对照试验报告,提取残疾数据收集情况,包括是否收集、如何收集、何时收集、由谁收集、所用测量工具及呈现结果。
主要发现
- 从407份试验报告中提取数据,无一项试验将残疾作为人口学特征收集。
- 27%(109/407)因其他目的收集部分残疾数据,如资格标准、功能结局测量或严重不良事件。
- 残疾最常通过问卷评估(65%;71/109),其次为临床评估(17%;19/109)和访谈(8%;9/109)。
- 在109份试验报告中,最常用的测量工具是认知功能测量简易精神状态检查,占总体15%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Improving clinical trial inclusivity for diverse populations, including people with disabilities, is crucial. Ethical considerations emphasize the need for trial enrollment to mirror the potential trial users' diversity, yet underrepresentation persists due to direct and indirect exclusions. The purpose of our study was to determine if trial teams collect data on people with disabilities for diversity monitoring purposes. We also examined how they collect disability and report it. STUDY DESIGN AND SETTING: We reviewed trial reports for randomized controlled trials published in the UK National Institute of Health Research library from 2016 to 2021. We extracted data on disability, including if, how and when it was collected, who collected it, the measurements used, and the results presented. RESULTS: We extracted data from 407 trial reports. Disability was not collected as a demographic characteristic in any trial. 27% (109/407) collected some disability data for other purposes, eg, eligibility, a measure of functional outcome or serious adverse events. Disability was most commonly assessed through questionnaires (65%; 71/109), clinical assessment (17%; 19/109), and interviews (8%; 9/109). A variety of measures were used to collect disability information. In 109 trial reports, the most common was a measure of cognitive function, the Mini Mental State Examination, which accounted for 15% overall. CONCLUSION: Disability is not just under recorded or underreported, it is ignored, in trials. As disability is not collected as a demographic characteristic, people with disabilities remain underserved in trials. Given 16% of the global population live with a disability, it is a threat to the generalizability of all trials and risks exacerbating health inequalities of people with a disability.
引用
- Cunningham S, Russell AM, Lidington E, et al. Lack of data collection in clinical trials prevents us from evaluating inclusion of people with disabilities. J Clin Epidemiol. 2025. PMID: 39924129. doi:10.1016/j.jclinepi.2025.111715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。